antimicrobial resistance Archives

Speaker Inerview with Emmanuel Normant for 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

August 9, 2019August 9, 2019 MarketsandMarkets Conferences

Philadelphia, USA August 09, 2019 – MarketsandMarkets recently interviewed Emmanuel Normant, Vice President, Preclinical Sciences, TG Therapeutics regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City. Emmanuel Normant is vice president of preclinical sciences at TG Therapeutics, a clinical-stage biotech company focused on hematologic cancers and located in New-York. There, he leads the three early pipeline programs, including a novel irreversible BTK inhibitor, and anti-PD-L1 monoclonal antibody and a bispecific antibody directed against CD19 and CD47. All three assets have entered…

UK Gov Launches 5-year Action-Plan and 20-year vision to Control Antimicrobial Resistance (AMR)

February 1, 2019February 4, 2019 MarketsandMarkets Conferences

A 5-year action plan has been published by the UK government on how UK will contribute to control and reduce AMR by 2040. The plan by the UK gov is made to cut down the number of drug-resistant infections by 10%, also reducing the use of antibiotics in human by 15% and prevent nearly 15,000 patients from contracting infections. The plan is to ensure current antibiotics remain powerful by reducing the quantity of resistant infections. Real-time patient data will be gathered by using new technology, which will help to understand…